Title:
FUSION PROTEIN USED FOR TREATING INTESTINAL DISEASE
Document Type and Number:
WIPO Patent Application WO/2018/077098
Kind Code:
A1
Abstract:
Provided is a fusion protein used for treating an intestinal disease and having the following structure: R-L-P, where R is a GLP-2 receptor agonist, L is a connecting peptide chain, and P is a long-acting carrier protein. The fusion protein provided in the present invention has significant biological activity and in vitro stability.
Inventors:
WEN XIAOFANG (CN)
HUANG YANSHAN (CN)
YANG ZHIYU (CN)
YAO GAOFENG (CN)
CHEN YONGLU (CN)
WANG XUELIAN (CN)
HUANG YANSHAN (CN)
YANG ZHIYU (CN)
YAO GAOFENG (CN)
CHEN YONGLU (CN)
WANG XUELIAN (CN)
Application Number:
PCT/CN2017/106727
Publication Date:
May 03, 2018
Filing Date:
October 18, 2017
Export Citation:
Assignee:
ZHEJIANG DOER BIOLOGICS CORP (CN)
International Classes:
A61K38/26; C07K19/00; A61K47/64; A61P1/00; C12N15/62
Domestic Patent References:
WO2007067828A2 | 2007-06-14 |
Foreign References:
CN101171262A | 2008-04-30 |
Download PDF: